Uncategorized
Biotech leaders call for streamlining of INDs as FDA’s Trialblazer rolls out
The FDA’s new investigational new drug pilot program—one part of HHS’s broader clinical trial modernization initiatives—has lofty goals to expedite first-in-human trials of novel drugs, but experts say it won’t tip the scales much on its own.